Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1

Interventions

Radiotherapy 2Methoxsalen 2merphos 1liposomal amphotericin B 1imetelstat 1atezolizumab 1Whole-Body Irradiation 1Watchful Waiting 1Vorinostat 1Vincristine 1VAP-cyclo protocol 1Ultraviolet Therapy 1Prednisone 1Photopheresis 1Pentostatin 1Palliative Care 1Nutritional Support 1Nicotine 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1Methotrexate 1Lenalidomide 1Etoposide 1EPOCH protocol 1Doxorubicin 1Dextromethorphan 1Cyclosporins 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sezary Syndrome × EPOCH protocol × Clear all
NCT00060385 2012-09-24

Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated
3 enrolled
DermatologicLymphoidOther hematologic neoplasm

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡